The differential effects of atorvastatin co-administered with ampicillin on the bacterial growth and biofilm formation of Staphylococcus aureus

作者: Rafael Vincent M. Manalo , Vivien Joyce D. Josol , Nina G. Gloriani

DOI: 10.1016/J.CMRP.2017.08.002

关键词:

摘要: Abstract Objectives In the past years, there have been increases in S. aureus infections, intensifying demand for new and effective drugs. Apparently, old drugs such as statins shown unexpected pleiotropic effects, may be exploited or repurposed to meet demands on antimicrobial therapy. this study, antibacterial activity of atorvastatin possible interactions with ampicillin were evaluated by determining minimum inhibitory concentration (MIC), synergism, biofilm inhibition these against ATCC 29213. Methods ampicillin, alone combination, tested property using MIC assay, synergism via checkerboard microdilution assay. Both then formation check its relevance sessile bacterial states. Results Atorvastatin did not display anti-bacterial consistent previous reports, but synergistically inhibited planktonic growth lowering 8-fold. Further, abrogated 48h-grown − implicative role chronic infection, lost when co-administered a ratio 1:1. Conclusion These suggest that fact targeting common pathway integral formation, warrants further verification mechanisms involved well identification novel enzyme off-targets could potentially impact treatment infections.

参考文章(26)
S. Hathroubi, S.-È. Fontaine-Gosselin, Y.D.N. Tremblay, J. Labrie, M. Jacques, Sub-inhibitory concentrations of penicillin G induce biofilm formation by field isolates of Actinobacillus pleuropneumoniae Veterinary Microbiology. ,vol. 179, pp. 277- 286 ,(2015) , 10.1016/J.VETMIC.2015.06.011
C.-J. Chen, Y.-C. Huang, New epidemiology of Staphylococcus aureus infection in Asia Clinical Microbiology and Infection. ,vol. 20, pp. 605- 623 ,(2014) , 10.1111/1469-0691.12705
Talita Signoreti Graziano, Maria Claudia Cuzzullin, Gilson Cesar Franco, Humberto Osvaldo Schwartz-Filho, Eduardo Dias de Andrade, Francisco Carlos Groppo, Karina Cogo-Müller, Statins and Antimicrobial Effects: Simvastatin as a Potential Drug against Staphylococcus aureus Biofilm. PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0128098
Steven Y. C. Tong, Joshua S. Davis, Emily Eichenberger, Thomas L. Holland, Vance G. Fowler, Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management Clinical Microbiology Reviews. ,vol. 28, pp. 603- 661 ,(2015) , 10.1128/CMR.00134-14
Henry Chambers, The changing epidemiology of Staphylococcus aureus Emerging Infectious Diseases. ,vol. 7, pp. 178- 182 ,(2001) , 10.3201/EID0702.010204
Siva Wu, Xiaojin Li, Manjula Gunawardana, Kathleen Maguire, Debbie Guerrero-Given, Christoph Schaudinn, Charles Wang, Marc M. Baum, Paul Webster, Beta- Lactam Antibiotics Stimulate Biofilm Formation in Non-Typeable Haemophilus influenzae by Up-Regulating Carbohydrate Metabolism PLoS ONE. ,vol. 9, pp. e99204- ,(2014) , 10.1371/JOURNAL.PONE.0099204
Michio Kurosu, Shajila Siricilla, Katsuhiko Mitachi, Advances in MRSA drug discovery: where are we and where do we need to be? Expert Opinion on Drug Discovery. ,vol. 8, pp. 1095- 1116 ,(2013) , 10.1517/17460441.2013.807246
N. Conceicao, C. d. C. H. B. de Oliveira, L. E. P. da Silva, L. R. C. de Souza, A. G. de Oliveira, Ampicillin Susceptibility Can Predict In Vitro Susceptibility of Penicillin-Resistant, Ampicillin-Susceptible Enterococcus faecalis Isolates to Amoxicillin but Not to Imipenem and Piperacillin Journal of Clinical Microbiology. ,vol. 50, pp. 3729- 3731 ,(2012) , 10.1128/JCM.01246-12
Jean-Luc Mainardi, Jean-Emmanuel Hugonnet, Filippo Rusconi, Martine Fourgeaud, Lionel Dubost, Angèle Nguekam Moumi, Vanessa Delfosse, Claudine Mayer, Laurent Gutmann, Louis B. Rice, Michel Arthur, Unexpected Inhibition of Peptidoglycan LD-Transpeptidase from Enterococcus faecium by the β-Lactam Imipenem * Journal of Biological Chemistry. ,vol. 282, pp. 30414- 30422 ,(2007) , 10.1074/JBC.M704286200